Skip to Main Content

Paper Details

The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.
BJU Int
15
2022
Author NameAffiliation
Steven HazellRoyal Marsden NHS Foundation Trust
Elizabeth BancroftInstitute of Cancer Research
Elizabeth BancroftRoyal Marsden NHS Foundation Trust
Zsofia Kote-JaraiInstitute of Cancer Research
Rosalind A EelesInstitute of Cancer Research
Rosalind A EelesRoyal Marsden NHS Foundation Trust
  • 1 - 6

Datasets

Release 1.2